The purpose of this RFA is to support new and innovative research relevant to Translational Science.
Proposed projects must be focused on translational science, i.e. focused on understanding a scientific or operational principle underlying a step of the translational process with the goal of developing generalizable principles to accelerate translational research. The intent of the award is to explore possible innovative new leads or new directions for established investigators, stimulate investigators from other areas to lend their expertise in research in clinical and translational science, and provide initial support to establish proof of concept. Translational research projects, i.e., project focused on crossing a particular step of the translational process for a particular target or disease, will not be considered.
For examples of studies that would be responsive, please see the Translational Science RFA.
These awards are open to all faculty with a rank of instructor or higher across the Atrium Health Enterprise including Atrium Health, Atrium Health Navicent, and Wake Forest Baptist Health, including Wake Forest University School of Medicine. Wake Forest University faculty and all CTSI affiliated institutions with a Wake Forest co-investigator are also invited to apply!
Download the RFA document below!
· October 14, 2022: LOI Deadline
· November 15, 2022: Invite for Full Application
· December 14, 2022: Full Applications Due
· March 8, 2022: Funding Decisions Communicated to Applicants
· July 1, 2023: Project Start Date